Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy

Clinical trial NCT02979561 · UNKNOWN

Trial details

NCT number: NCT02979561
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Angiographically Confirmed Acute Massive Pulmonary Embolism Treated With Endovascular Mechanical Fragmentation and Thrombolytic Therapy

Start date: 2016-10-01
Primary completion: 2018-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.